GoodRx , the leading platform for medication savings in the U.S., today announced two major initiatives to make FDA-approved GLP-1 medications more widely available. First, the launch of GoodRx for ...

The drugmaker said it has started selling higher doses of the injectable treatment for $349 a month to patients paying the full bill.

McGraw Hill, Inc. ("McGraw Hill" or the "Company"), a leading global provider of education solutions for preK-12, higher education and professional learning, announced today the launch and wider ...

The move also underscored the power of the charitable foundations that hold sway over some of Denmark’s biggest and most successful businesses, including brewer Carlsberg A/S, shipping giant A.P.

Novo Nordisk today announced that Wegovy® (semaglutide) injection 0.25 mg and 0.5 mg and Ozempic® are now available at a limited time price of $199 per month to new self-pay patients between now and ...

Comprehensive Documentation Confirms Production-Ready Architecture for PetVivo’s Veterinary Platform Launching Q1 2026 ...

Extends cash runway into first half of 2027, beyond planned first half of 2026 proof of concept ('POC”)data readouts of SIM0505 (CDH6 ADC) and LNCB74 (B7-H4 ADC)Led by Ikarian Capital, Squadron ...